India Infertility Treatments Market Opportunities, 2020
In India, infertility is a highly sensitive matter and is linked with serious psychological, emotional and social distress to an individual as well as to his/her family. About 10-15% of Indian married couples were believed to be suffering from infertility in 2014. Infertility occurs in both males and females; however, female infertility dominates the infertility treatments market in India. On an average, approximately 40,000 infertility treatment cycles are being performed across the country every year. For curing infertility, three treatments, namely, Fertility Drugs, Surgery, and Assisted Reproductive Treatments (ARTs), are being adopted across the country. Among these treatments, ART is the most widely adopted treatment option as it involves handing of both male sperm and female egg, which is not possible in other two types of treatments.
According to Pharmaion report, “India Infertility Treatments Market Opportunities, 2020”, infertility treatments market in India is anticipated to grow at a CAGR of over 13% during 2015 - 2020. Growth in the market is anticipated on account of visible increase in the reproductive age of women, changing lifestyle, increasing use of contraceptives and rising consumption of alcohol and cigarettes. The largest market share in India infertility treatments market was captured by the country’s Southern region, due to increasing medical tourism and easy availability of skilled medical professionals in the region. Owing to lesser government regulations and absence of a centralized regulatory body, India infertility treatments market is being dominated by small and unbranded players. Some of the major players operating in India infertility treatments market include Nova IVI Fertility, Bourn Hall International India Pvt. Ltd., Morpheus Life Sciences Pvt. Ltd., and Dr. Rama's Institute for Fertility, among others. “India Infertility Treatments Market Opportunities, 2020” discusses the following aspects related to infertility treatments market in India:
The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with infertility treatment clinics & hospitals, research institutes and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.
According to Pharmaion report, “India Infertility Treatments Market Opportunities, 2020”, infertility treatments market in India is anticipated to grow at a CAGR of over 13% during 2015 - 2020. Growth in the market is anticipated on account of visible increase in the reproductive age of women, changing lifestyle, increasing use of contraceptives and rising consumption of alcohol and cigarettes. The largest market share in India infertility treatments market was captured by the country’s Southern region, due to increasing medical tourism and easy availability of skilled medical professionals in the region. Owing to lesser government regulations and absence of a centralized regulatory body, India infertility treatments market is being dominated by small and unbranded players. Some of the major players operating in India infertility treatments market include Nova IVI Fertility, Bourn Hall International India Pvt. Ltd., Morpheus Life Sciences Pvt. Ltd., and Dr. Rama's Institute for Fertility, among others. “India Infertility Treatments Market Opportunities, 2020” discusses the following aspects related to infertility treatments market in India:
- India Infertility Treatments Market Size, Share & Forecast
- Segmental Analysis – By Type, By Region & By Company Type
- Policy & Regulatory Landscape
- Changing Market Trends & Emerging Opportunities
- Competitive Landscape & Strategic Recommendations
- To identify the on-going trends and anticipated growth over the next five years
- To gain competitive knowledge of leading market players
- To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer’s specific needs.
The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with infertility treatment clinics & hospitals, research institutes and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.
1. PRODUCT OVERVIEW
2. ANALYST VIEW
3. RESEARCH METHODOLOGY
4. GLOBAL FERTILITY TREATMENTS MARKET OVERVIEW
5. INDIA FERTILITY TREATMENTS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (ART, Fertility Drugs & Surgery)
5.2.2. By Region (South, West, North & Others)
5.2.3. By Company Type (Branded & Unbranded)
6. INDIA FERTILITY DRUGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Hormonal Drugs & Synthetic Drugs)
6.2.2. By Gender (Female & Male)
6.2.2.1. Hormonal Drugs
6.2.2.2. Synthetic Drugs
7. INDIA INFERTILITY TREATMENT SURGERY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Gender (Female & Male)
8. INDIA ART MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (IVF, Surrogacy, IUI & Others)
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
10.1. Medical Tourism & Fertility Tourism
10.2. Rising Secondary Infertility
10.3. Increasing Penetration of Infertility Clinics in Small Towns
10.4. AMH for Testing Ovarian Reserve
10.5. Array CGH for Detecting Genetic Abnormalities
11. POLICY & REGULATORY LANDSCAPE
12. INDIA ECONOMIC PROFILE
13. COMPETITION LANDSCAPE
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. Nova IVI Fertility
13.2.2. Bourn Hall International India Pvt. Ltd.
13.2.3. Morpheus Life Sciences Pvt. Ltd.
13.2.4. Dr. Rama's Institute for Fertility
13.2.5. Moolchand Fertility & IVF
13.2.6. Sun Pharmaceutical Industries Ltd.
13.2.7. Cadila Healthcare Ltd.
13.2.8. Cipla Ltd.
13.2.9. Abbott India Limited
13.2.10. GlaxoSmithKline Pharmaceuticals Limited
14. STRATEGIC RECOMMENDATIONS
2. ANALYST VIEW
3. RESEARCH METHODOLOGY
4. GLOBAL FERTILITY TREATMENTS MARKET OVERVIEW
5. INDIA FERTILITY TREATMENTS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (ART, Fertility Drugs & Surgery)
5.2.2. By Region (South, West, North & Others)
5.2.3. By Company Type (Branded & Unbranded)
6. INDIA FERTILITY DRUGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Hormonal Drugs & Synthetic Drugs)
6.2.2. By Gender (Female & Male)
6.2.2.1. Hormonal Drugs
6.2.2.2. Synthetic Drugs
7. INDIA INFERTILITY TREATMENT SURGERY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Gender (Female & Male)
8. INDIA ART MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (IVF, Surrogacy, IUI & Others)
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
10.1. Medical Tourism & Fertility Tourism
10.2. Rising Secondary Infertility
10.3. Increasing Penetration of Infertility Clinics in Small Towns
10.4. AMH for Testing Ovarian Reserve
10.5. Array CGH for Detecting Genetic Abnormalities
11. POLICY & REGULATORY LANDSCAPE
12. INDIA ECONOMIC PROFILE
13. COMPETITION LANDSCAPE
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. Nova IVI Fertility
13.2.2. Bourn Hall International India Pvt. Ltd.
13.2.3. Morpheus Life Sciences Pvt. Ltd.
13.2.4. Dr. Rama's Institute for Fertility
13.2.5. Moolchand Fertility & IVF
13.2.6. Sun Pharmaceutical Industries Ltd.
13.2.7. Cadila Healthcare Ltd.
13.2.8. Cipla Ltd.
13.2.9. Abbott India Limited
13.2.10. GlaxoSmithKline Pharmaceuticals Limited
14. STRATEGIC RECOMMENDATIONS
LIST OF TABLES
Table 1: Risk Factors Leading to Infertility
Table 2: Infertility Treatment Drugs – Pros & Cons
Table 3: Surgery for Infertility Treatment – Pros & Cons
Table 4: Types of ART Treatments
Table 5: ART – Pros & Cons
Table 6: South India Female Infertility Prevalence Rate, 2014 (%)
Table 7: West India Female Infertility Prevalence Rate, 2014 (%)
Table 8: North India Female Infertility Prevalence Rate, 2014 (%)
Table 9: North India Female Infertility Prevalence Rate, 2014 (%)
Table 10: Surgical Sperm Retrieval Procedures Required in Various ART Treatments
Table 11: Secondary Infertility Cases in Major Indian Cities, 2014
Table 12: Number of Infertility Clinics, By State, 2014
Table 1: Risk Factors Leading to Infertility
Table 2: Infertility Treatment Drugs – Pros & Cons
Table 3: Surgery for Infertility Treatment – Pros & Cons
Table 4: Types of ART Treatments
Table 5: ART – Pros & Cons
Table 6: South India Female Infertility Prevalence Rate, 2014 (%)
Table 7: West India Female Infertility Prevalence Rate, 2014 (%)
Table 8: North India Female Infertility Prevalence Rate, 2014 (%)
Table 9: North India Female Infertility Prevalence Rate, 2014 (%)
Table 10: Surgical Sperm Retrieval Procedures Required in Various ART Treatments
Table 11: Secondary Infertility Cases in Major Indian Cities, 2014
Table 12: Number of Infertility Clinics, By State, 2014
LIST OF FIGURES
Figure 1: India Infertility Treatments Market Size, By Value, 2010-2020F (USD Billion)
Figure 2: Share of Infertility Factor among Indian Couples, 2014
Figure 3: India Infertility Treatments Market Share, By Type, By Value, 2010-2020F
Figure 4: India Infertility Treatments Market Share, By Region, By Value, 2010-2020F
Figure 5: India Infertility Treatments Market Share, By Company Type, By Value, 2010-2020F
Figure 6: India Fertility Drugs Market Size, By Value, 2010-2020F (USD Billion)
Figure 7: India Fertility Drugs Market Share, By Type, By Value, 2010-2020F
Figure 8: India Fertility Drugs Market Share, By Gender, By Value, 2014 & 2020F
Figure 9: India Fertility Hormonal Drugs Market Share, By Gender, By Value, 2010-2020F
Figure 10: India Fertility Synthetic Drugs Market Share, By Gender, By Value, 2010-2020F
Figure 11: India Infertility Treatment Surgery Market Size, By Value, 2010-2020F (USD Billion)
Figure 12: India Infertility Treatment Surgery Market Share, By Gender, By Value, 2010-2020F
Figure 13: India ART Market Size, By Value, 2010-2020F (USD Billion)
Figure 14: India ART Market Share, By Type, By Value, 2010-2020F
Figure 15: India Medical Tourism Market Size, By Value, 2010-2020F (USD Billion)
Figure 16: India Medical Tourists Share, By State, 2013
COMPANIES MENTIONED
1. Nova IVI Fertility
2. Bourn Hall International India Pvt. Ltd.
3. Morpheus Life Sciences Pvt. Ltd.
4. Dr. Rama's Institute for Fertility
5. Moolchand Fertility & IVF
6. Sun Pharmaceutical Industries Ltd.
7. Cadila Healthcare Ltd.
8. Cipla Ltd.
9. Abbott India Limited
10. GlaxoSmithKline Pharmaceuticals Limited
Figure 1: India Infertility Treatments Market Size, By Value, 2010-2020F (USD Billion)
Figure 2: Share of Infertility Factor among Indian Couples, 2014
Figure 3: India Infertility Treatments Market Share, By Type, By Value, 2010-2020F
Figure 4: India Infertility Treatments Market Share, By Region, By Value, 2010-2020F
Figure 5: India Infertility Treatments Market Share, By Company Type, By Value, 2010-2020F
Figure 6: India Fertility Drugs Market Size, By Value, 2010-2020F (USD Billion)
Figure 7: India Fertility Drugs Market Share, By Type, By Value, 2010-2020F
Figure 8: India Fertility Drugs Market Share, By Gender, By Value, 2014 & 2020F
Figure 9: India Fertility Hormonal Drugs Market Share, By Gender, By Value, 2010-2020F
Figure 10: India Fertility Synthetic Drugs Market Share, By Gender, By Value, 2010-2020F
Figure 11: India Infertility Treatment Surgery Market Size, By Value, 2010-2020F (USD Billion)
Figure 12: India Infertility Treatment Surgery Market Share, By Gender, By Value, 2010-2020F
Figure 13: India ART Market Size, By Value, 2010-2020F (USD Billion)
Figure 14: India ART Market Share, By Type, By Value, 2010-2020F
Figure 15: India Medical Tourism Market Size, By Value, 2010-2020F (USD Billion)
Figure 16: India Medical Tourists Share, By State, 2013
COMPANIES MENTIONED
1. Nova IVI Fertility
2. Bourn Hall International India Pvt. Ltd.
3. Morpheus Life Sciences Pvt. Ltd.
4. Dr. Rama's Institute for Fertility
5. Moolchand Fertility & IVF
6. Sun Pharmaceutical Industries Ltd.
7. Cadila Healthcare Ltd.
8. Cipla Ltd.
9. Abbott India Limited
10. GlaxoSmithKline Pharmaceuticals Limited
